Excipients in Pharmaceuticals Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Excipients in Pharmaceuticals Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Excipients in Pharmaceuticals by Material: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Organic Excipients

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Inorganic Excipients

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  USP Water

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Excipients in Pharmaceuticals: by Dosage Form: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Solid Form

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Liquid Dosage Form

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Semi-Solid Dosage Form

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Others

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Excipients in Pharmaceuticals by Route of Administration: Market Size and Forecast, 2019 - 2028 

6.1  Overview

6.2  Injectable

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Oral

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.4  Topical

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.5  Advanced Drug Delivery Systems and Others

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Excipients in Pharmaceuticals by End User: Market Size and Forecast, 2019 - 2028

7.1  Overview

7.2  Pharmaceutical Companies

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

7.3  Contract Formulators

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

7.4  Research Institutes

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

7.5  Others

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 8        Global Excipients in Pharmaceuticals by Geography: Market Size and Forecast, 2019 - 2028

8.1  Overview

8.1.1   Global Excipients in Pharmaceuticals Market Year-on-Year Growth, by region 2020 – 2028 (%)

8.2  North America

8.2.1   Current Trend and Analysis

8.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

8.2.3   U.S.

8.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.2.3.2        By Material

8.2.3.3        By Dosage Form

8.2.3.4        By Route of Administration

8.2.3.5        By End User

8.2.4   Canada

8.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.2.4.2        By Material

8.2.4.3        By Dosage Form

8.2.4.4        By Route of Administration

8.2.4.5        By End User

8.2.5   Mexico

8.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.2.5.2        By Material

8.2.5.3        By Dosage Form

8.2.5.4        By Route of Administration

8.2.5.5        By End User

8.3    Europe

8.3.1   Current Trend and Analysis

8.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.3   UK

8.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.3.2        By Material

8.3.3.3        By Dosage Form

8.3.3.4        By Route of Administration

8.3.3.5        By End User

8.3.4   Russia

8.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.4.2        By Material

8.3.4.3        By Dosage Form

8.3.4.4        By Route of Administration

8.3.4.5        By End User

8.3.5   France

8.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.5.2        By Material

8.3.5.3        By Dosage Form

8.3.5.4        By Route of Administration

8.3.5.5        By End User

8.3.6   Italy

8.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.6.2        By Material

8.3.6.3        By Dosage Form

8.3.6.4        By Route of Administration

8.3.6.5        By End User

8.3.7   Germany

8.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.7.2        By Material

8.3.7.3        By Dosage Form

8.3.7.4        By Route of Administration

8.3.7.5        By End User

8.3.8   Rest of Europe

8.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.8.2        By Material

8.3.8.3        By Dosage Form

8.3.8.4        By Route of Administration

8.3.8.5        By End User

8.4    Asia-Pacific

8.4.1   Current Trend and Analysis

8.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

8.4.3   China

8.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.4.3.2        By Material

8.4.3.3        By Dosage Form

8.4.3.4        By Route of Administration

8.4.3.5        By End User

8.4.4   India

8.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.4.4.2        By Material

8.4.4.3        By Dosage Form

8.4.4.4        By Route of Administration

8.4.4.5        By End User

8.4.5   Japan

8.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.4.5.2        By Material

8.4.5.3        By Dosage Form

8.4.5.4        By Route of Administration

8.4.5.5        By End User

8.4.6   Rest of Asia-Pacific

8.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.4.6.2        By Material

8.4.6.3        By Dosage Form

8.4.6.4        By Route of Administration

8.4.6.5        By End User

8.5    RoW

8.5.1   Current Trend and Analysis

8.5.2   Market Size and Forecast

8.5.3   South America

8.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.5.3.2        By Material

8.5.3.3        By Dosage Form

8.5.3.4        By Route of Administration

8.5.3.5        By End User

8.5.4   Middle East

8.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.5.4.2        By Material

8.5.4.3        By Dosage Form

8.5.4.4        By Route of Administration

8.5.4.5        By End User

8.5.5   Africa

8.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

8.5.5.2        By Material

8.5.5.3        By Dosage Form

8.5.5.4        By Route of Administration

8.5.5.5        By End User

Chapter 9        Company Profiles

9.1  Ashland Global Holdings Inc.

9.1.1     Company Overview

9.1.2     Product Portfolio

9.1.3     Business Strategies

9.1.4     Financials

9.1.5     Recent Developments

9.2  Avantor Performance Materials

9.2.1     Company Overview

9.2.2     Product Portfolio

9.2.3     Business Strategies

9.2.4     Financials

9.2.5     Recent Developments

9.3  Basf AG

9.3.1     Company Overview

9.3.2     Product Portfolio

9.3.3     Business Strategies

9.3.4     Financials

9.3.5     Recent Developments

9.4  Cargill Inc.

9.4.1     Company Overview

9.4.2     Product Portfolio

9.4.3     Business Strategies

9.4.4     Financials

9.4.5     Recent Developments

9.5  Croda International

9.5.1     Company Overview

9.5.2     Product Portfolio

9.5.3     Business Strategies

9.5.4     Financials

9.5.5     Recent Developments

9.6  Ctd Holdinga Inc.

9.6.1     Company Overview

9.6.2     Product Portfolio

9.6.3     Business Strategies

9.6.4     Financials

9.6.5     Recent Developments

9.7  Dowdupont

9.7.1     Company Overview

9.7.2     Product Portfolio

9.7.3     Business Strategies

9.7.4     Financials

9.7.5     Recent Developments

9.8  Gattefosse

9.8.1     Company Overview

9.8.2     Product Portfolio